attention deficit-hyperactivity disorder. Attention-deficit hyperactivity disorder, unspecified type
Conditions
Interventions
Intervention 1: Intervention group: 30 patients receive Ritalin (Novarits company, Riralin). Intervention 2: Intervention group: 30 patients receive Atomoxetin (Abidi company, Stramox).
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 14 Years
Inclusion criteria
Inclusion criteria: ADHD disorder (all types) was diagnosed on the base of attention deficit-hyperactivity DSM-V system criteria. patients with ADHD diagnosis who were maltreated cardiac, renal or chronic diseases which have required special care. patients haven’t used MAOI drugs during recent 15 days
Exclusion criteria
Exclusion criteria: Exclusion criteria: eating disorders; substance use disorders; psychiatric disorders such as tic, mental, pervasive developmental disorders,personal or familial history of Turette syndrome; seizure; history of Hyperthyroidism, glaucoma; using of drugs that are contraindicated with Ritalin or tomoxetin; patients with history of no response to prior medications of ADHD; occurrence of menstruation in girls.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADHD-RS questionnaire. Timepoint: at the end of 4th and 8th weeks after starting treatment. Method of measurement: ADHD-RS questionnaire or attention deficit hyper activity disorder rating scale is a questionnaire which has 18 questions used for a measurement of ADHD recovery in different studies.Time for filling out the questionnaire is about 5 minutes.Psychologist asks questions from children and then completes the form of questionnaire and rates the answers. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAnjela Hamidia
Babol University of Medical Sciences
Outcome results
None listed